Mesoblast stock reports fiscal revenue of USD 120.3 million

Published on 10/08/2026 at 08:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Mesoblast stock carries a Hold consensus from 3 analysts. Fiscal 2026 net loss narrowed to USD 57.5 million from USD 102.1 million.

MESO, AU000000MSB8, Illustration mit AI erstellt.

Mesoblast Limited (ISIN AU000000MSB8) reported fiscal 2026 revenue of USD 120.3 million, up from USD 17.2 million in fiscal 2025. The stock was last at USD 13.94 on October 7, 2026, at 4:00 p.m. ET, up 2.42 percent on Nasdaq.

Revenue reached USD 120.3 million

According to Simply Wall St, fiscal 2026 revenue rose by USD 103.1 million from fiscal 2025, while net loss narrowed 44 percent to USD 57.5 million from USD 102.1 million. The reported fiscal year ended June 30, 2026, so the result reflects Mesoblast's first full year of commercial Ryoncil sales.

The revenue increase was paired with a smaller loss per share. Fiscal 2026 loss per share was USD 0.044, compared with USD 0.085 in fiscal 2025, according to Simply Wall St.

State Street filing adds a shareholder signal

Mesoblast's investor-relations filing dated October 1, 2026, states that State Street Bank and Trust Company ceased to be a substantial holder on September 29, 2026. The filing describes securities-lending activity, making the disclosure a record of holding status rather than a stated change to Mesoblast's operating outlook.

The commercial picture therefore rests on two different signals: revenue has expanded sharply from a low base, while the company remains loss-making and shareholder disclosures can change through lending arrangements. That combination leaves product execution and cash use as important measures for the next update.

Hold consensus has USD 39.00 target

MarketBeat lists a Hold consensus based on 3 analysts on its October 7, 2026 page. The average, high and low price target are each USD 39.00, while the published rating mix includes 2 buys and 1 sell.

For investors, the central comparison is not only the target valuation but also the distance between commercial growth and profitability. Fiscal 2026 revenue reached USD 120.3 million, yet operating cash flow was negative USD 43.83 million for the year.

MESO stock was last at USD 13.94

MESO stock was last at USD 13.94 on Nasdaq on October 7, 2026 at 4:00 p.m. ET, with a 52-week range of USD 13.05 to USD 21.50 and market capitalization of USD 1.8 billion.